Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
etoricoxib + paracetamol (Thrift Pharmaceuticals)
- Development stage
- Preclinical
- Lead developer
- Thrift Pharmaceuticals
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Fancox is a fixed-dose combination tablet containing etoricoxib and paracetamol (acetaminophen), developed and marketed by Thrift Pharmaceuticals. Etoricoxib is a highly selective cyclooxygenase-2 (COX-2) inhibitor that reduces the synthesis of inflammatory prostaglandins. Paracetamol is a widely used central analgesic and antipyretic agent. Together, they provide synergistic, dual-action relief from pain and inflammation with a lower risk of gastrointestinal side effects compared to traditional non-selective nonsteroidal anti-inflammatory drugs (NSAIDs). Fancox is approved and marketed for managing mild-to-moderate pain and inflammation associated with musculoskeletal disorders, joint diseases, and post-operative recovery.
- Brand names
- Fancox
- Other names
- etoricoxib + acetaminophenetoricoxib + paracetamoletoricoxib and acetaminophenetoricoxib and paracetamoletoricoxib/acetaminophenetoricoxib/paracetamol
02
Targets
PGHS-1 (Prostaglandin G/H Synthase 1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)
Beyond the preview
Go deeper on etoricoxib + paracetamol (Thrift Pharmaceuticals).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on etoricoxib + paracetamol (Thrift Pharmaceuticals).